Formulation and In vitro evaluation of Solid- Self- Emulsifying Drug Delivery System (SEDDS) of Glibenclamide

Published on Aug 30, 2013in American Journal of Advanced Drug Delivery
Maria Saifee5
Estimated H-index: 5
Sharda Zarekar1
Estimated H-index: 1
+ 3 AuthorsShailesh Burande1
Estimated H-index: 1
Aim of present study was to develop solid self micro emulsifying drug delivery system (S-SEDDS) with Aerosil 200 for enhancement of dissolution rate of model drug Glibenclamide (GBM). SEDDS was prepared using Capmul MCM C8 TM , Cremophor RH 40 TM , and Transcutol P TM as oil, surfactant and cosurfactant respectively. For formulation of stable SEDDS, micro emulsion region was identified by constructing pseudo ternary phase diagram containing different proportion of surfactant: co-surfactant (1:1, 2:1 and 3:1), oil and water. Prepared SEDDS was evaluated for turbidity measurement, globule size and zeta potential, viscosity determination and % transmittance. S-SEDDS was prepared by adsorption technique using Aerosil 200 as solid carrier. Prepared S-SEDDS was evaluated for flow properties, drug content, FTIR, SEM, DSC and in-vitro dissolution study. Results showed that prepared liquid SEDDS passed all evaluation tests. Globule size was found to be 142.8 nm with polydispersity index 0.396. S-SEDDS showed good flow property and drug content. From the experiment, it is clear thateven after conversion of the liquid SEDDS into the solid one there was no significant alteration in the properties of solid SEDDS. in-vitro dissolution studies showed that there was enhancement of dissolution rate of GBM as compared with that of plain drug and marketed formulation. From the results it is concluded that, Aerosil 200 can be used to develop S-SEDDS by adsorption technique to enhance dissolution rate of poorly water soluble model drug GBM.
Figures & Tables
📖 Papers frequently viewed together
Aim of present study was to develop solid self micro emulsifying drug delivery system (S-SMEDDS) with Neusilin US2 for enhancement of dissolution rate of Telmisartan (TEL). SMEDDS was prepared using Oleic acid, Tween 80 and PEG 400 as oil, surfactant and cosurfactant respectively. For formulation of stable SMEDDS, micro emulsion region was identified by constructing pseudo ternary phase diagram containing different proportion of surfactant: co-surfactant (Km value 1:1, 2:1 and 3:1), oil and wate...
#1Chao Wu (SPU: Shenyang Pharmaceutical University)H-Index: 4
#2Zhongyan Wang (SPU: Shenyang Pharmaceutical University)H-Index: 7
Last. Siling Wang (SPU: Shenyang Pharmaceutical University)H-Index: 53
view all 6 authors...
Abstract A biodegradable porous starch foam (BPSF) was developed for the first time as a carrier in order to improve the dissolution and enhance the oral bioavailability of lovastatin – defined as a model poorly water soluble BCS type II drug. In this paper, BPSF was prepared by the solvent exchange method and characterized by scanning electron microscopy (SEM) and nitrogen adsorption/desorption analysis in order to perform the morphological and structural characterization of BPSF. Lovastatin wa...
Bioavailability is defined as the rate and extent (amount) of absorption of unchanged drug from its dosage form. It is one of the important parameter to achieve desired concentration of drug in systemic circulation for pharmacological response to be shown. A drug with poor bioavailability is one with poor aqueous solubility, slow dissolution rate in biological fluids, poor stability of dissolved drug at physiological pH, poor permeation through biomembrane, extensive presystemic metabolism. Poor...
#1Manish K SinghH-Index: 1
#2Vikas ChH-Index: 1
Last. Suman RamtekeH-Index: 13
view all 4 authors...
In the present work glipizide based microemulsion was developed and its usefulness as topical drug carrier system for the non-insulin dependent diabetes mellitus (NIDDM) was investigated. Microemulsion was prepared by water titration method using oleic acid as oil phase, tween-80 as surfactant and propylene glycol as co-surfactant. Menthol as a permeation enhancer was added to a final drug-loaded microemulsion formulation at the level of 1% w/w. Microemulsions were characterized for pseudo-terna...
#1Ajeet Kumar Singh (Dabur Research Foundation)H-Index: 6
#2Akash Chaurasiya (Hamdard University)H-Index: 6
Last. Rama MukherjeeH-Index: 22
view all 7 authors...
Limited aqueous solubility of exemestane leads to high variability in absorption after oral administration. To improve the solubility and bioavailability of exemestane, the self-microemulsifying drug delivery system (SMEDDS) was developed. SMEDDS comprises of isotropic mixture of natural or synthetic oil, surfactant, and cosurfactant, which, upon dilution with aqueous media, spontaneously form fine o/w microemulsion with less than 100 nm in droplet size. Solubility of exemestane were determined ...
The objective of the present investigation was to develop and evaluate self-microemulsifying drug delivery system (SMEDDS) for improving the delivery of a BCS class II antidiabetic agent, glyburide (GLY). The solubility of GLY in oils, cosurfactants, and surfactants was evaluated to identify the components of the microemulsion. The ternary diagram was plotted to identify the area of microemulsion existence. The in vitro dissolution profile of GLY SMEDDS was evaluated in comparison to the markete...
#1Suman KatteboinaH-Index: 1
As a consequence of modern drug discovery techniques, there has been a steady increase in the number of new pharmacologically active lipophilic compounds that are poorly water-soluble. It is a great challenge for pharmaceutical scientists to convert those molecules into orally administered formulations with sufficient bioavailability. Among the approaches to improve the oral bioavailability of these molecules, the use of self-emulsified drug delivery systems (SEDDS) has been shown to be reasonab...
Approximately 40 per cent of new drug candidates have poor water solubility and the oral delivery of such drugs is frequently associated with implications of low bioavailability, high intra and inter-subject variability, and lack of dose proportionality. Bioavailability problem of lipophillic drugs can be solved by formation of Self-Micro Emulsifying Drug Delivery System (SMEDDS). SMEDDS appears to be a unique and industrially feasible approach to overcome the problem of low oral bioavailability...
#1Jingling TangH-Index: 7
#2Jin SunH-Index: 2
Last. Zhonggui HeH-Index: 2
view all 3 authors...
Drugs are most often administered by the oral route. However, more than 40% of new chemical entities exhibit poor aqueous solubility, resulting in unsatisfactory oral drug delivery. Recently, much attention has been focused on self- emulsifying drug delivery systems (SEDDS) to improve the oral bioavailability of poorly aqueous soluble drugs. SEDDS are isotropic mixtures of oil, surfactants, solvents and co-solvents/surfactants. The principal characteristic of these systems is their ability to fo...
#1R. Neslihan Gürsoy (Hacettepe University)H-Index: 8
#2Simon Benita (HUJI: Hebrew University of Jerusalem)H-Index: 50
Abstract The oral delivery of hydrophobic drugs presents a major challenge because of the low aqueous solubility of such compounds. Self-emulsifying drug delivery systems (SEDDS), which are isotropic mixtures of oils, surfactants, solvents and co-solvents/surfactants, can be used for the design of formulations in order to improve the oral absorption of highly lipophilic drug compounds. SEDDS can be orally administered in soft or hard gelatin capsules and form fine relatively stable oil−in−water ...
Cited By5
#1Eun Sol Ha (PNU: Pusan National University)H-Index: 11
#2Seon Kwang Lee (PNU: Pusan National University)H-Index: 3
Last. Min-Soo Kim (PNU: Pusan National University)H-Index: 28
view all 6 authors...
Background Diethylene glycol monoethyl ether (DEGEE) is produced via the O-alkylation of ethanol with two ethylene oxide units, followed by distillation. It has a long history of safe use in food and personal-care products, and is used as an effective strong solubilizer in oral, topical, transdermal, and injectable human and veterinary pharmaceutical products. It has been used as a pharmaceutical solvent for many years under the trade name transcutol. DEGEE, a hydroalcoholic solvent, is gaining ...
ABSTRACTThe main objective of this study was to prepare a solid self-microemulsifying drug delivery system (S-SMEDDS) by spray drying liquid SMEDDS with an inert solid carrier Aerosil 200 to improve the dissolution rate and permeability of chlorthalidone (CTD). The liquid SMEDDS was composed of CTD, oleic acid, tween 20, and PEG 200. Preliminary screening was performed to select proper component combination. Solubility of CTD was determined in various vehicles. Ternary phase diagram for four ser...
#2S. BharathH-Index: 10
Last. Varadharajan MadhavanH-Index: 6
view all 3 authors...
Self emulsifying drug delivery systems (SEDDS) are isotropic mixtures of oil, surfactant and co-surfactant which are generally present in the form of liquid or semi-solid. Solid- SEDDS (S-SEDDS) are solid forms of liquid SEDDS converted into solid by suitable means. Candesartan cilexetil a Biopharmaceutical classification system (BCS) Class II drug is a nonpeptide angiotensin II type 1(AT1) receptor antagonist used in the treatment of hypertension. It has an oral bioavailability of 15% because t...
About 40% of the drug candidates have poor water solubility due to their low bioavailability. Self-emulsifying drug delivery systems (SEDDs) are mixtures of oils, surfactants and co-surfactants, which efficiently improve dissolution and bioavalabilty of sparingly soluble drugs by rapid self-emulsification. SEDDs belongs to lipid formulations, and size ranges from 100nm (SEDDs) to less than 50nm (SMEDDs). Lipophilic drugs can be dissolved in such systems, enabling them to be administered as a uni...
#1C. AparnaH-Index: 4
#2Prathima SrinivasH-Index: 2
Last. Sri VenkateshwaraH-Index: 2
view all 4 authors...
The Objective of present study was to develop a solid self-emulsifying drug delivery system (SEDDS) of ranolazine to enhance its oral bioavailability. Ranolazine is an anti anginal drug used in the treatment of cardiovascular diseases like chronic angina, ischemia. Solubility of ranolazine in various oils was determined to optimize the oil phase of a SEDDS. Various surfactants and co-surfactants were screened for their ability to emulsify the selected oil. Pseudo ternary phase diagrams were cons...
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.